Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal.
about
Barrett's oesophagus and adenocarcinomaManagement of the patient with incomplete response to PPI therapy.Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppressionModelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease.Hiatal hernia predisposes to nocturnal gastro-oesophageal reflux.The influence of the speed of food intake on multichannel impedance in patients with gastro-oesophageal reflux disease.Symptomatic reflux disease: the present, the past and the future.Esophagogastric junction distensibility after fundoplication assessed with a novel functional luminal imaging probeGastroesophageal reflux and altered motility in lung transplant rejection.Pathophysiology and treatment of Barrett's esophagus.Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP)Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosationEfficacy of half-solid nutrient for the elderly patients with percutaneous endoscopic gastrostomy.Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.Republished: symptomatic reflux disease: the present, the past and the future.Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover studyMechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infectionConditions for acid catalysed luminal nitrosation are maximal at the gastric cardia.High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran.Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux.Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.A review of rabeprazole in the treatment of acid-related diseasesAn alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patientsLiquid in the gastroesophageal segment promotes reflux, but compliance does not: a mathematical modeling studyEtiologic factors of gastric cardiac adenocarcinoma among men in Taiwan.Esophageal impedance monitoring for gastroesophageal reflux.Measuring movement and location of the gastroesophageal junction: research and clinical implications.Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure.Pathophysiology of gastroesophageal reflux disease: new understanding in a new era.Effect of alginate in patients with GERD hiatal hernia matters.The Relationship Between the Acid Pocket and GERD.Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease.Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
P2860
Q24791935-1692EFBF-16BA-4B11-AC4E-4E813F8DCB18Q27025882-46B72378-8CCA-4FF8-8FC5-F1A410F8CC27Q28195953-FD16109F-8951-4BCE-8C78-44DCD28B60F6Q31105336-83A574D1-82C6-4607-91AF-233D4040255CQ33210792-7C02693A-6EB6-4132-AC7B-5DA6B41C0861Q33695368-D704EAC6-416B-4FB0-89A7-20EAAD2D6CD5Q33695458-D155B68A-5F18-421E-831B-1C4E432BD588Q33834731-614640DD-E566-4D93-8157-5A44743963D4Q33881626-33AFE8EE-D795-4D1F-8A48-480B4DBA18EBQ34026147-C7394A41-138C-405B-96BA-34CC5C3B6757Q34063695-E316D18A-0D08-4AB7-BF97-3DB25BF47E0CQ34483969-522DAF89-C9F8-49D3-8269-706111377661Q34676749-6247A40F-E17D-4C5E-BD80-E576DD97AC0FQ34853045-434C4B3B-471A-43A4-90ED-7524D3BDD65EQ35010979-777BE1CD-D79F-48E2-B450-4AECB1F9DA55Q35048270-5E99979A-302C-4F20-9DE6-3542F2AD0094Q35129666-133AF803-7C03-48A0-896C-C2CC1CCFF778Q35162477-7D755B02-15ED-47C1-9444-1CAABB9D1232Q35588464-F4C0B664-9B31-4BB7-86CF-886931E6BF01Q35595869-2900454E-4A6A-47AC-8714-C8E9D343D3EEQ35596764-855F9BC5-B755-4B2C-A67A-3E75A48248A7Q35598291-0295AC5F-B0AB-4313-A4DA-EEE426155E81Q35761321-C13F9DA5-2FAD-4F0A-8489-F2C36732DEFBQ36041651-8864AAB7-E2C5-4A37-91B4-5902262C577EQ36041656-FDC939B0-A3B1-42BD-A08A-42398D398AC5Q36398674-671FACF8-3EB7-4AAF-AAA2-2FFD3BFFF184Q36661321-86E25A4F-D70D-41CE-8275-4F6BFB3ECB35Q36730470-7F675B4E-035F-405A-9170-5904352ED2F7Q36977066-0E86BAC7-D2E8-4223-890B-142812504E66Q37423029-9D33C697-577E-43EE-BBB8-6561103ABCB9Q37829303-7D432E75-AB82-46A0-8179-92B5699F4F0FQ38064516-896CEB25-C8B0-4F66-9F9A-A62A82CE5A30Q38191675-D0CCA0F8-98CE-4000-B67B-02A65FC23374Q38520220-1742D72D-C807-4125-AD45-2E0AB3BE6A15Q38599589-7FFB3055-DFE5-43C1-8308-A7B04E67F29AQ38713799-C7ABF6D9-2AF4-4603-9D5E-41DDBA906F03Q39104046-FA70C0D3-4E16-4E72-B8E6-59C3CAB0CBB7Q39212872-40E09CB0-242C-4F59-BE97-9BDA533C47DAQ39220802-340B7349-1557-4D95-A7C6-75E0568237D3Q39396442-87B98166-7B34-4C83-AB27-89AC8D878CA3
P2860
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@en
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@nl
type
label
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@en
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@nl
prefLabel
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@en
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@nl
P2093
P356
P1433
P1476
Unbuffered highly acidic gastr ...... phageal junction after a meal.
@en
P2093
P304
P356
10.1053/GAST.2001.27997
P407
P577
2001-10-01T00:00:00Z